DURHAM, N.C. & SEATTLE-- November 13, 2023--Pioneering epigenome editing company Tune Therapeutics has announced it is working on a new and potentially curative approach to treating chronic HBV infection. The...
Wake Forest University School of Medicine Develops Digital Platform to Better Care for Stroke Patients
August 9, 2022: Pappas managed Catalyst Fund provides funding to develop Wake Forest University School of Medicine digital platform.
